Since 2020, nearly 400 million people have been left in the wake of COVID-19 not by death but by a quieter, more confounding diminishment — chronic fatigue, brain fog, and bodies that collapse under the weight of ordinary effort. Science has long struggled to explain why, but a team of researchers now proposes that the answer may lie in blood vessel cells driven into a kind of cellular limbo by viral infection: neither fully alive nor cleared away, persisting as agents of inflammation and vascular disorder. This hypothesis, if confirmed through ongoing clinical trials, would not only illuminat
Researchers propose 'zombie cells' mechanism behind long-COVID and chronic fatigue
Millions of long-COVID patients experience chronic fatigue, brain fog, exercise intolerance, and post-exertional malaise that significantly impairs quality of life and functional capacity.
The zombie cells evade destruction. The disease entrench.
Mark
Why does the immune system fail to clear these senescent cells in long-COVID when it normally would?
Mimi
That's the crux of it. The virus doesn't just damage the endothelial cells—it also damages the immune system's ability to respond. You get impaired natural-killer cells, sluggish macrophages. And the senescent cells themselves actively evade immune attack by releasing chemical signals that repel the immune system. It's a trap.
Mark
So the virus creates both the problem and the conditions for the problem to persist?
Mimi
Exactly. The virus infects the blood vessel cells and pushes them into senescence. But it also leaves the immune system weakened or confused. The zombie cells then exploit that weakness. It's a vicious cycle.
Mark
If this hypothesis is correct, why haven't we seen this mechanism clearly before?
Mimi
Because it requires looking at multiple systems at once—the blood vessels, the clotting cascade, the immune response, the oxygen delivery to tissues. Most research has focused on one piece. This framework connects them all through a single cellular event: senescence.
Mark
What happens if the clinical trials confirm this?
Mimi
Then you have a testable target. You could develop drugs that either prevent cells from becoming senescent in the first place, or that help the immune system clear the ones that already exist. That's a path to actual treatment, not just symptom management.
Mark
How long might it take to get from here to a therapy?
Mimi
The trials are already running. If the imaging and blood tests work, if they can reliably identify senescent cells in patients, then the next phase is drug development. Years, probably. But for the first time, there's a mechanism to target.
Il Polso
- Nearly 400 million long-COVID patients have endured years of debilitating symptoms — fatigue, brain fog, post-exertional collapse — without medicine offering a coherent biological explanation for their suffering.
- Researchers now identify a potential culprit: endothelial 'zombie cells' driven into senescence by viruses like SARS-CoV-2, which linger in blood vessel walls releasing inflammatory signals and promoting microclots that starve tissues of oxygen.
- The dysfunction is self-reinforcing — senescent cells chemically repel the immune system that should destroy them, while exhausted natural-killer cells and sluggish macrophages fail to clear the threat, locking patients in a cycle of vascular and immune breakdown.
- Clinical trials are now underway in the United States, with researchers developing blood tests, fluorescent imaging probes, and lab models to locate these cells in living patients and understand what sustains them.
- If the hypothesis holds, therapies targeting senescent endothelial cells directly could restore blood flow, reduce inflammation, and begin to lift the burden from one of the largest cohorts of chronically ill people in modern history.
Since 2020, nearly 400 million people have been left in the wake of COVID-19 not by death but by a quieter, more confounding diminishment — chronic fatigue, brain fog, and bodies that collapse under the weight of ordinary effort. Science has long struggled to explain why, but a team of researchers now proposes that the answer may lie in blood vessel cells driven into a kind of cellular limbo by viral infection: neither fully alive nor cleared away, persisting as agents of inflammation and vascular disorder. This hypothesis, if confirmed through ongoing clinical trials, would not only illuminate one of medicine's most contested conditions but potentially open the first targeted path toward healing for millions.
Nearly 400 million people have developed long-COVID since 2020, and roughly half now meet the clinical definition of myalgic encephalomyelitis or chronic fatigue syndrome. They live with exhaustion, mental fog, exercise intolerance, and post-exertional malaise — symptoms that can worsen for days after even mild physical activity. Despite decades of patient reports and a global surge in cases, medicine has lacked a coherent explanation for what is happening inside the body.
A team of researchers studying blood and cardiovascular inflammation now proposes a mechanism that could change that. Their hypothesis centers on endothelial cells — the inner lining of blood vessels — that are driven into cellular senescence by viral infection. These so-called zombie cells stop dividing but remain metabolically active, continuously releasing inflammatory molecules and promoting blood clotting. Viruses including SARS-CoV-2, influenza A, and Epstein-Barr virus are among those implicated. Once infected, these cells become trapped in a half-alive state, resistant to immune clearance.
What makes the hypothesis compelling is how it unifies long-COVID's scattered symptoms into a single biological story. Senescent endothelial cells promote microclot formation while preventing those clots from dissolving, slowing blood flow and reducing oxygen delivery to muscles and organs. During exercise, compromised vessels constrict rather than dilate, triggering the characteristic post-exertional crash. In the brain, faulty vessel cells allow blood flow to drop and leak across the blood-brain barrier, producing fog and dizziness. In the gut, they weaken the intestinal lining, allowing bacterial fragments into the bloodstream and fueling further inflammation.
The persistence of these cells depends on a second layer of dysfunction: immune exhaustion. Long-COVID patients frequently show impaired natural-killer cell function, sluggish macrophages, and complement dysfunction — and the senescent cells themselves emit signals that repel immune attack. This creates a self-sustaining loop in which zombie cells evade destruction, the immune system remains dysregulated, and vascular damage endures.
The research is now moving from theory to clinical testing. A registered trial in the United States is investigating senescence in long-COVID patients, while the research team develops diagnostic tools — including laboratory models, non-invasive imaging, and fluorescent probes — to locate these cells in living patients. The goal is to identify what circulating substances drive their formation and design therapies that target them directly, with the hope of restoring vascular function and reducing the burden of illness for millions.
Nearly 400 million people have developed long-COVID since the pandemic began in 2020. Many of them—roughly half—now meet the clinical definition of myalgic encephalomyelitis or chronic fatigue syndrome, a condition the World Health Organization recognizes as a post-viral fatigue syndrome and a brain disorder. They live with chronic exhaustion, mental fog, an inability to tolerate exercise without crashing, dizziness, muscle and joint pain, and digestive problems. The worst part, for many, is post-exertional malaise: symptoms that worsen dramatically after physical activity, sometimes for days. Yet despite decades of patient reports and now a global surge in cases, medicine has lacked a coherent explanation for what is actually happening inside the body.
A team of researchers studying blood and cardiovascular inflammation now proposes a mechanism that could change that. Their hypothesis centers on what they call "zombie cells"—endothelial cells, which form the inner lining of blood vessels, that have been driven into a state of cellular senescence by viral infection. These cells stop dividing but remain metabolically active, continuously releasing molecules that trigger inflammation and blood clotting. The viruses implicated include SARS-CoV-2, influenza A, Epstein-Barr virus, and several others known to directly infect blood vessel linings. Once infected, these cells become trapped in a half-alive state, unable to function normally but resistant to immune clearance.
What makes this hypothesis compelling is how it weaves together the scattered symptoms of long-COVID into a single biological narrative. When senescent endothelial cells accumulate in blood vessels, they promote the formation of microclots and simultaneously prevent those clots from breaking down. Blood flow slows. Oxygen delivery to muscles and organs diminishes, explaining the profound fatigue. During exercise, the problem intensifies: instead of dilating to meet increased oxygen demand, the compromised vessels constrict further, starving muscles of blood and triggering the characteristic post-exertional crash. In the brain, the same faulty cells allow blood flow to drop and leak across the blood-brain barrier, producing brain fog and dizziness. In the gut, they weaken the intestinal lining, allowing bacterial fragments to enter the bloodstream and fuel ongoing inflammation. Because blood vessels permeate every tissue, even scattered patches of these zombie cells can generate the constellation of symptoms patients experience.
The persistence of these cells depends on a second layer of dysfunction: immune exhaustion. Normally, the body's natural-killer cells, macrophages, and complement proteins would identify and destroy senescent cells. But long-COVID and ME/CFS patients frequently show impaired natural-killer function, sluggish macrophages, and complement dysfunction. Worse, the senescent endothelial cells themselves emit chemical signals that repel immune attack. This creates a self-sustaining loop. The zombie cells evade destruction. The immune system remains confused and overactive. The vascular dysfunction persists. In a healthy person with a functioning immune system, these senescent cells would normally be cleared within weeks. But in long-COVID, the immune dysfunction allows them to survive and the disease to entrench.
The research is moving from theory to clinical testing. A registered trial in the United States is investigating senescence in long-COVID patients. The research consortium is developing new diagnostic tools: they expose healthy endothelial cells in the laboratory to blood drawn from long-COVID patients to see whether that blood drives the cells into senescence. Simultaneously, they are testing non-invasive imaging techniques and fluorescent probes that could one day identify aging cells inside living patients, with tissue biopsies confirming findings in selected cases. The goal is straightforward but ambitious—find these zombie cells in real patients, understand what circulating substances drive their formation, and then design therapies that target senescent cells directly. If successful, such treatments could restore vascular function and reduce the disease burden that has disabled millions.
Citazioni salienti
In a healthy person with an optimally functioning immune system, these senescent endothelial cells will normally be cleared. But there is significant immune dysfunction in ME/CFS and long-COVID, and this may enable the zombie cells to survive and the disease to progress.— Research team studying post-viral conditions
Vuoi la storia completa?
Leggi l'originale su The Conversation ↗
Health & Medicine